Brian LaMoreaux

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Top Venues

Rheumatology and therapy

Arthritis care & research

ACR open rheumatology

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Emily E Holladay, Amy S Mudano, Fenglong Xie, Jingyi Zhang, Ted R Mikuls, Kenneth G Saag, Huifeng Yun, Brian LaMoreaux, Megan Francis Sedlak, Jeffrey R Curtis
Real-World Effectiveness of Pegloticase Associated With Use of Concomitant Immunomodulatory Therapy. Arthritis care & research (2024)
Emily E Holladay, Amy S Mudano, Fenglong Xie, Jingyi Zhang, Ted R Mikuls, Kenneth G Saag, Huifeng Yun, Brian LaMoreaux, Megan Francis Sedlak, Jeffrey R Curtis
Real-World Effectiveness of Pegloticase Associated with Use of Concomitant Immunomodulatory Therapy. Arthritis care & research (2024)
Zsuzsanna H McMahan, Daniel E Furst, Justin W Li, Qian Meng, Yuan Yuan, Tamara Lesperance, Kenyatta Peoples, Farah Ali, Brian LaMoreaux, Stephanie D Taylor
Economic and Health Care Resource Use Burden of Systemic Sclerosis. ACR open rheumatology (2023)
Anthony J Amatucci, Lissa Padnick-Silver, Brian LaMoreaux, David H Bulbin
Comparison Between Early-Onset and Common Gout: A Systematic Literature Review. Rheumatology and therapy (2023)
John K Botson, Kenneth Saag, Jeff Peterson, Katie Obermeyer, Yan Xin, Brian LaMoreaux, Lissa Padnick-Silver, Supra Verma, Suneet Grewal, Amar Majjhoo, John R P Tesser, Michael E Weinblatt
A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12-Month Findings. ACR open rheumatology (2023)
Aaron Broadwell, John A Albert, Lissa Padnick-Silver, Brian LaMoreaux
Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout. Rheumatology and therapy 9 (6) (2022)
John K Botson, Kenneth Saag, Jeff Peterson, Naval Parikh, Stephen Ong, Dan La, Karon LoCicero, Katie Obermeyer, Yan Xin, Jason Chamberlain, Brian LaMoreaux, Supra Verma, Stephen Sainati, Suneet Grewal, Amar Majjhoo, John R P Tesser, Michael E Weinblatt
A Randomized Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR RCT): Primary Efficacy and Safety Findings. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Karim Richard Masri, Lissa Padnick-Silver, Kevin Winterling, Brian LaMoreaux
Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study. Rheumatology and therapy 9 (2) (2022)
Naomi Schlesinger, Lissa Padnick-Silver, Brian LaMoreaux
Enhancing the Response Rate to Recombinant Uricases in Patients with Gout. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (2) (2022)
Robert T Keenan, Herbert S B Baraf, Brian LaMoreaux
Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase. Rheumatology and therapy 6 (2) (2019)